Therapeutic effect of taxanes on metastatic breast cancer of various immunohistochemical subtypes

Ítems similars

• The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel
  per: Fukada, Ippei, et al.
  Publicat: (2017)
• The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.
  per: Ippei Fukada, et al.
  Publicat: (2017-01-01)
• Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine
  per: Fukuda, Takayo, et al.
  Publicat: (2015)
• Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer
  per: Fukada, Ippei, et al.
  Publicat: (2016)
• Imatinib could be a new strategy for pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in metastatic breast cancer
  per: Fukada, Ippei, et al.
  Publicat: (2016)